The firm was part of the litigation team that assisted in resolving the claims of approximately 10,000 Actos® users who claimed to have been injured by the drug. Designed and prescribed to help type-2 diabetics control their blood sugar, patients utilizing Actos were diagnosed with bladder cancer at a high rate. After several verdicts in favor of various Plaintiffs, Takeda Pharmaceuticals and its affiliated businesses was driven to enter into a settlement with 10,000 users of this diabetes medication, a number of whom the Napoli Shkolnik legal group was representing. Consequently, Takeda agreed to a $2.4 billion dollar settlement to resolve these cases